Aripiprazole side effects
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Aripiprazole: A Comprehensive Overview
Common Side Effects of Aripiprazole
Aripiprazole, an atypical antipsychotic, is widely used for treating various psychiatric conditions, including schizophrenia, bipolar disorder, and borderline personality disorder. Despite its efficacy, aripiprazole is associated with several side effects. Commonly reported side effects include headache, insomnia, nausea, numbness, constipation, and anxiety . These side effects are generally mild but can impact the patient's quality of life.
Extrapyramidal Symptoms (EPS)
Extrapyramidal symptoms (EPS) are a significant concern with antipsychotic medications. Aripiprazole, however, has a relatively low incidence of EPS compared to other antipsychotics. A meta-analysis revealed that the mean incidence of EPS in children and adolescents treated with aripiprazole was 17.1%, with specific symptoms like parkinsonism and tremor being more common than in those treated with placebo . Another study noted that EPS were uncommon even at high D2 receptor occupancy levels, which is typically associated with a higher risk of these symptoms .
Metabolic Side Effects
Aripiprazole is generally considered to have a favorable metabolic side-effect profile. However, some studies have reported weight gain and increased body mass index (BMI) in children and adolescents, particularly those younger than 12 years . This suggests that while aripiprazole may be better than other antipsychotics in terms of metabolic side effects, it is not entirely free from these issues.
Hyperprolactinemia
Hyperprolactinemia, a condition characterized by elevated levels of prolactin, is a common side effect of many antipsychotics. Aripiprazole, however, has been shown to reduce serum prolactin levels. In a study involving patients with hyperprolactinemia induced by haloperidol, adjunctive treatment with aripiprazole normalized prolactin levels in 88.5% of patients . This makes aripiprazole a favorable option for patients who experience hyperprolactinemia with other antipsychotics.
Impulse-Control Disorders
Aripiprazole has been implicated in impulse-control disorders such as pathological gambling, hypersexuality, and compulsive eating. These side effects are thought to be due to its partial agonist activity at dopamine D3 receptors, which can create a hyperdopaminergic state in the mesolimbic pathway . Although these cases are relatively rare, they highlight the need for careful monitoring of patients on aripiprazole, especially those with a history of impulse-control issues.
Conclusion
Aripiprazole is a versatile antipsychotic with a generally favorable side-effect profile. Common side effects include headache, insomnia, and nausea, while more serious side effects like EPS and metabolic changes are less frequent compared to other antipsychotics. However, clinicians should be aware of the potential for hyperprolactinemia reduction and the rare but significant risk of impulse-control disorders. Monitoring and individualized treatment plans are essential to mitigate these risks and ensure the best outcomes for patients.
Sources and full results
Most relevant research papers on this topic